NCT02641938View on ClinicalTrials.gov

Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Malignant Tumor
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine group :1ug/kg IV loading over 20 minutes followed by 0.5ug/kg/hr IV infusion after induction of anesthesia until the completion of the surgery

DRUG

Normal Saline

Control group :IV loading and infusion of same volume of normal saline after induction of anesthesia until the completion of the surgery

Trial Locations (1)

Unknown

GangnamSH, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT02641938 - Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury | Biotech Hunter | Biotech Hunter